» Articles » PMID: 21785622

New Perspectives on Chinese Herbal Medicine (zhong-yao) Research and Development

Overview
Date 2011 Jul 26
PMID 21785622
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Synthetic chemical drugs, while being efficacious in the clinical management of many diseases, are often associated with undesirable side effects in patients. It is now clear that the need of therapeutic intervention in many clinical conditions cannot be satisfactorily met by synthetic chemical drugs. Since the research and development of new chemical drugs remain time-consuming, capital-intensive and risky, much effort has been put in the search for alternative routes for drug discovery in China. This narrative review illustrates various approaches to the research and drug discovery in Chinese herbal medicine. Although this article focuses on Chinese traditional drugs, it is also conducive to the development of other traditional remedies and innovative drug discovery.

Citing Articles

Therapeutic Options in Alzheimer's Disease: From Classic Acetylcholinesterase Inhibitors to Multi-Target Drugs with Pleiotropic Activity.

Cacabelos R, Martinez-Iglesias O, Cacabelos N, Carrera I, Corzo L, Naidoo V Life (Basel). 2025; 14(12.

PMID: 39768263 PMC: 11678002. DOI: 10.3390/life14121555.


Jingzhi Guanxin Oral Liquids Attenuate Atherosclerotic Coronary Heart Disease via Modulating Lipid Metabolism and PPAR-Related Targets.

Wang X, Hu T, Jiang Y, He Y, Li P, Peng W Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931451 PMC: 11206304. DOI: 10.3390/ph17060784.


Potential traditional Chinese medicines with anti-inflammation in the prevention of heart failure following myocardial infarction.

Zhang Z, Chen F, Wan J, Liu X Chin Med. 2023; 18(1):28.

PMID: 36932409 PMC: 10022008. DOI: 10.1186/s13020-023-00732-w.


Suchilactone inhibits the growth of acute myeloid leukaemia by inactivating SHP2.

Wu J, Deng Y, Zhang X, Ma J, Zheng X, Chen Y Pharm Biol. 2021; 60(1):144-153.

PMID: 34962431 PMC: 8725822. DOI: 10.1080/13880209.2021.2017467.


The Use of Chinese Yang/Qi-Invigorating Tonic Botanical Drugs/Herbal Formulations in Ameliorating Chronic Kidney Disease by Enhancing Mitochondrial Function.

Tian J, Huang Y, Wu T, Huang H, Ko K, Zhu B Front Pharmacol. 2021; 12:622498.

PMID: 34248614 PMC: 8264145. DOI: 10.3389/fphar.2021.622498.


References
1.
Antoniades C, Tousoulis D, Koumallos N, Marinou K, Stefanadis C . Levosimendan: beyond its simple inotropic effect in heart failure. Pharmacol Ther. 2007; 114(2):184-97. DOI: 10.1016/j.pharmthera.2007.01.008. View

2.
Meshnick S . Artemisinin antimalarials: mechanisms of action and resistance. Med Trop (Mars). 1999; 58(3 Suppl):13-7. View

3.
Jeong C, Murthy H, Hahn E, Paek K . Improved production of ginsenosides in suspension cultures of ginseng by medium replenishment strategy. J Biosci Bioeng. 2008; 105(3):288-91. DOI: 10.1263/jbb.105.288. View

4.
Homma M, Ishihara M, Qian W, Kohda Y . [Effects of long term administration of Shakuyaku-kanzo-To and Shosaiko-To on serum potassium levels]. Yakugaku Zasshi. 2006; 126(10):973-8. DOI: 10.1248/yakushi.126.973. View

5.
Li W, Kan K, Carlier P, Pang Y, Han Y . East meets West in the search for Alzheimer's therapeutics - novel dimeric inhibitors from tacrine and huperzine A. Curr Alzheimer Res. 2007; 4(4):386-96. DOI: 10.2174/156720507781788918. View